back to top
My wish lists
Save your wish list
If you want to add more content to your wish list, simply log in. If you do not have a user account, please register for the Hanser Customer Center.

» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.
Your wish lists
If you want to use your wish list during your next visit, simply log in. If you do not have a user account, please register for the Hanser Customer Center.
» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.

« Back

Your advantages at a glance

  • One login for all Hanser portals
  • Individual home page for faster access to preferred content
  • Exclusive access to selected content
  • Personal wish lists on all portals
  • Central management of your personal information and newsletter subscriptions

Register now
Deutsch
Bookmark Bookmarked
12-06-2013

Evonik Starts Innovation Campaign

Innovation and efficient research are today already the hallmarks of Evonik, but the specialty chemicals company wants to build up these strengths even more.

"This is why we launched our Leading Innovation initiative last fall. With our global Leading Innovation initiative we are promoting a culture of innovation, with courage to break new ground, in which our employees are encouraged to take risks and which is based on trust, close cooperation and openness and which also rewards courage to innovate. Everyone at Evonik has to embrace innovation", says Dr. Peter Nagler, Chief Innovation Officer of Evonik.

Evonik is already a company with a strong focus on innovation. The Group is very efficient in translating its research expenses into patents. That was confirmed by the Patent Asset Index (PAI), which rated Evonik as a leader in this area. The specialty chemicals company has more than 26,000 patents and patent applications. The company filed patent applications for around 260 new inventions in the year 2012.

Evonik regards biotechnology as an important technology platform and high-potential innovation area. Given the changing availability of resources, Evonik is committed to become more independent of fossil fuels and individual renewable resources. For this purpose, the scientists of the specialty chemicals company are exploring the third generation of biotechnology, which is capable of using various waste materials as a basis instead of sugar or plant residues. The laboratories of the strategic innovation unit Creavis have succeeded in generating 2-hydroxy isobutyric acid, or 2-HIBA for short, from syngas with biotechnology methods. 2-HIBA is a precursor for Plexiglas and syngas can be generated, for instance, from waste streams.

Furthermore, using a completely new technology, two-phase fermentation, Evonik is now able to manufacture a precursor of the highperformance polymer polyamide 12 from palm kernel oil. A pilot plant for the production of ω-amino lauric acid (ALA) went onstream in Slovenska Lupca (Slovakia) in early 2013. In the long term, the new procedure will supplement the petroleum-based production of Polyamid12.

additional links
Company profile

Evonik Industries AG

Kirschenallee
DE 64293 Darmstadt
Tel.: 06151 18-01
Fax: 06151 18-02

Newsletter

Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?

Subscribe here

Subscribe here

Job Advertisements

Looking for a new challenge? Check out our jobs market!

Job Advertisements

Patents Stimulate Innovation

Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.

Patents